DE69637676D1 - Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION - Google Patents

Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION

Info

Publication number
DE69637676D1
DE69637676D1 DE69637676T DE69637676T DE69637676D1 DE 69637676 D1 DE69637676 D1 DE 69637676D1 DE 69637676 T DE69637676 T DE 69637676T DE 69637676 T DE69637676 T DE 69637676T DE 69637676 D1 DE69637676 D1 DE 69637676D1
Authority
DE
Germany
Prior art keywords
lysines
locally administered
vascular function
improve vascular
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69637676T
Other languages
English (en)
Inventor
John P Cooke
Victor J Dzau
Gary H Gibbons
Sverin Schwarzacher
Tai T Lim
Alan C Yeung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R UNIVERSITY
Original Assignee
R UNIVERSITY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/556,035 external-priority patent/US5891459A/en
Priority claimed from US08/695,792 external-priority patent/US5852058A/en
Application filed by R UNIVERSITY filed Critical R UNIVERSITY
Application granted granted Critical
Publication of DE69637676D1 publication Critical patent/DE69637676D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69637676T 1995-11-09 1996-10-24 Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION Expired - Fee Related DE69637676D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/556,035 US5891459A (en) 1993-06-11 1995-11-09 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US08/695,792 US5852058A (en) 1993-06-11 1996-08-12 Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
PCT/US1996/017241 WO1997016983A1 (en) 1995-11-09 1996-10-24 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity

Publications (1)

Publication Number Publication Date
DE69637676D1 true DE69637676D1 (de) 2008-10-23

Family

ID=24794481

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637676T Expired - Fee Related DE69637676D1 (de) 1995-11-09 1996-10-24 Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION

Country Status (4)

Country Link
EP (1) EP1003500A4 (de)
JP (1) JP2000516612A (de)
DE (1) DE69637676D1 (de)
WO (1) WO1998006389A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6587718B2 (en) 1999-10-08 2003-07-01 Scimed Life Systems, Inc. Iontophoretic delivery to heart tissue
US6706274B2 (en) 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
EP3556401A1 (de) 2005-05-27 2019-10-23 The University of North Carolina at Chapel Hill Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
EP2467173B8 (de) 2009-08-21 2019-06-19 Novan, Inc. Wundverbände, verfahren zu ihrer anwendung und verfahren zu ihrer herstellung
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236413B1 (en) * 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
US5499971A (en) * 1990-06-15 1996-03-19 Cortrak Medical, Inc. Method for iontophoretically delivering drug adjacent to a heart
US5498238A (en) * 1990-06-15 1996-03-12 Cortrak Medical, Inc. Simultaneous angioplasty and phoretic drug delivery
AU655780B2 (en) * 1990-10-30 1995-01-12 Clintec Nutrition Company A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors
US5428070A (en) * 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5482925A (en) * 1994-03-17 1996-01-09 Comedicus Incorporated Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
US5681278A (en) * 1994-06-23 1997-10-28 Cormedics Corp. Coronary vasculature treatment method

Also Published As

Publication number Publication date
EP1003500A1 (de) 2000-05-31
WO1998006389A1 (en) 1998-02-19
EP1003500A4 (de) 2004-06-23
JP2000516612A (ja) 2000-12-12

Similar Documents

Publication Publication Date Title
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
DE69034018D1 (de) Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
FI981017A0 (fi) Proteiinien uutto hiilidioksidiin
DE69633333D1 (de) Diphosphonatderivate von therapeutischen substanzen
AU7236596A (en) Transdermal administration of ropinirole and analogs thereof
ATE235887T1 (de) Verwendung von wässerigen arzneimittelzubereitungen zur erzeugung treibgasfreier aerosole
ATE205694T1 (de) Triacetin zur erhöhung der transdermalen penetration
DE69631157D1 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes
ATA98488A (de) Pharmazeutische verwendung von 17-ketosteroiden
NO963049D0 (no) Modulatorer av forankrende proteinfunksjon
DE69604347D1 (de) Bestimmung der dynamischen Eigenschaften von Programmen
AT388096B (de) Implantat zur befestigung von zahnprothesen
NO961959L (no) Rensing av hemoglobin
DE69841311D1 (de) Prothese zur linderung von kiefergelenkproblemen
DE69836139D1 (de) Verfahren zur behandlung von vaskulären proliferativen erkrankungen mit p27 und fusionen davon
DE69430731D1 (de) Implantierbarer herzschrittmacher zur beendigung von herzarrhythmie
DE69406302T2 (de) Verwendung von östriolmessungen zur uberwachung tokolytischer therapie
DE69637676D1 (de) Verwendung von lokal verabreichten Lysine zur VERBESSERUNG DER VASKULAREN FUNKTION
DE59610713D1 (de) Elektrodenkatheter zur kartierenden erfassung von reizleitungsstrukturen
DE19681439T1 (de) Modifizierung von Polypeptidarzneimitteln zur Erhöhung des Elektrotransportflusses
IS4532A (is) Notkun Melatóníns til meðferðar lyfjafíkla
DE69600212T3 (de) Verwendung von Monocarbonsäuren zur Pflege von Keratinsubstanzen
DE69017825D1 (de) Heilverfahren von Lebererkrankungen mit Verwendung von Pyrrol-Chinolin-Chinone-Triester und neue Pyrrol-Chinolin-Chinone-Triester.
FI103866B1 (fi) Ankkurointielementti tekonivelen nivelmekanismin tukemiseksi
DE59308823D1 (de) Verwendung von Thioalkandionen als Aromastoffe

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee